Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Condition(s):Kidney DiseaseLast Updated:June 7, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Kidney DiseaseLast Updated:June 7, 2013Completed
Condition(s):Chronic Kidney DiseasesLast Updated:June 24, 2020Completed
Condition(s):Diabetic Kidney DiseaseLast Updated:May 5, 2022Completed
Condition(s):Diabetic Kidney DiseaseLast Updated:March 22, 2024Recruiting
Condition(s):Chronic Kidney DiseaseLast Updated:December 22, 2017Completed
Condition(s):Chronic Kidney DiseasesLast Updated:March 10, 2022Completed
Condition(s):Diabetic Kidney DiseaseLast Updated:January 11, 2021Recruiting
Condition(s):Polycystic Kidney DiseaseLast Updated:December 1, 2016Completed
Condition(s):Polycystic Kidney DiseaseLast Updated:October 19, 2023Recruiting
Condition(s):Diabetic Kidney DiseaseLast Updated:March 13, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.